Senior Medical Director, Global Clinical Development Oncology

优缺点分析

角色解读

• This senior director role can advance to Executive Director or VP-level positions in clinical development or therapeutic area leadership.
• Opportunities to lead larger program portfolios, influence company-wide R&D strategy, and take on global governance responsibilities.
• Potential transition into broader medical affairs or R&D executive roles, leveraging deep regulatory and clinical expertise.
• Lead and shape clinical development strategy for oncology programs from Phase 1 through Phase III, including regulatory submissions and Health Authority interactions.
• Provide senior medical leadership on study design, execution, and data interpretation, integrating clinical, translational, and biomarker data into decision-making.
• Guide indication strategy, patient selection, and dose optimization, while collaborating with cross-functional global teams.
• Oversee safety and efficacy data review, and contribute to key clinical and regulatory documents.
• MD degree with strong oncology expertise and at least 5 years of industry experience in clinical R&D.
• Deep understanding of clinical development phases, regulatory requirements (FDA/EMA/ICH-GCP), and dossier preparation.
• Ability to interpret complex clinical data and lead cross-functional, matrixed, international teams.
• Excellent English communication and strategic thinking skills, with a global mindset.

申请策略

• Align your application with the company's 'United As One for Patients' mission, demonstrating patient-centric thinking.
• Be prepared to discuss examples of how you've influenced development strategy and handled regulatory complexity.
• Highlight MD, oncology board certifications, and 5+ years in clinical R&D within pharma/biotech.
• Emphasize experience leading Phase 1-3 studies, regulatory submissions, and Health Authority interactions.
• Showcase specific oncology areas like solid tumors, targeted therapies, or ADCs, and any biomarker-driven development projects.
• Demonstrate leadership in cross-functional, global matrix teams with concrete examples of strategic contributions.
• If lacking, deepen knowledge of regulatory processes (FDA/EMA) and ICH-GCP guidelines.
• Familiarize with precision medicine and biomarker strategies, as well as statistical and translational data interpretation.

面试指南

• For experience-based questions, use the STAR method (Situation, Task, Action, Result) to structure your responses.
• For strategy questions, show your understanding of benefit-risk assessment and patient-centric development, with examples of balancing scientific rigor and regulatory feasibility.
• For leadership questions, emphasize your ability to influence without authority and align diverse stakeholders.
• How have you designed and executed a clinical development plan for an oncology asset from Phase 1 to registration?
• Describe a time you interacted with Health Authorities (FDA/EMA). How did you prepare and handle challenging feedback?
• How do you integrate biomarker and translational data into early clinical development decisions?
• Tell me about your experience leading cross-functional global teams in a matrix environment.
• How would you approach dose optimization for a novel ADC in solid tumors?